Stem Cell Therapy Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
The estimated value of the global stem cell therapy market is
$286 million in 2023 and is expected to grow to USD 1.5 billion by 2034, with a
compound annual growth rate (CAGR) of 16.5% from 2024 to 2034. They are
important in the treatment of blood diseases and malignancies. Numerous goals
are achieved by stem cell therapy, such as tissue regeneration, immunological
modulation, drug development, and personalized medicine.
Stem cell therapy is the application of stem cells for the
prevention or treatment of diseases or disorders. The body's special stem cells
have the ability to differentiate into a wide variety of cell types with
various functions. Because they can repair damaged tissues and organs, they are
a valuable tool in medical study and treatment.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/stem-cell-therapy-market
GROWTH DRIVERS
The primary driver of the growth in the stem cell treatment
industry is the increased funding for stem cell research. Encouraging a climate
conducive to stem cell therapy research and development requires government
measures and financial support. The investment accelerates the progress of
clinical trials, facilitates the translation of research discoveries into
practical therapeutic applications, increases industrial capacity and
infrastructure, and supports the general expansion and development of the stem cell treatment market.
MARKET
SEGMENTATION:
By Type -
· Adult
Stem Cells (ASCs)
o Hematopoietic
o Mesenchymal
o Neural
o Epithelial/Skin
o Others
· Induced
Pluripotent Stem Cells (iPSCs)
· Embryonic
Stem Cells (ESCs)
· Human
Embryonic Stem Cells (HESCs)
· Other
Stem Cells
By Therapy Type -
· Autologous
Stem Cell Therapy
· Allogenic
Stem Cell Therapy
By Cell Source -
· Bone
Marrow
· Adipose
Tissue
· Placental/Umbilical
Cord Blood
· Dental
Pulp
· Others
By Application -
· Neurological
Disorders
· Cardiovascular
Diseases
· Orthopedic
Treatments
· Oncology
· Diabetes
· Surgeries
· Inflammatory
& Autoimmune Diseases
· Wound
Healing and Tissue Regeneration
· Others
By End-User -
· Hospitals
& Clinics
· Research
Institutes
· Biotechnology
Companies
· Contract
Research Organizations (CROs)
By Region -
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East and Africa
Global Key
Players:
· Athersys
Inc.
· Mesoblast
Ltd
· Biorestorative
Therapies Inc.
· Pluristem
Inc.
· Brainstorm
Cell Limited
· ViaCyte
Inc.
· Gamida
Cell
· HOPE
BIOSCIENCES
· Cellular
Biomedicine Group
· Smith
& Nephew
· MEDIPOST
· ANTEROGEN.
C.O., LTD.
· NuVasive
Inc.
· RTI
Surgical
· AlloSource
· JCR
Pharmaceuticals Co. Ltd.
· Takeda
Pharmaceutical Company Limited
For
More Information about this Report @ https://www.xresearch.biz/shop/stem-cell-therapy-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment